Synthesis and antiprotozoal activity of pyridyl analogues of pentamidine.

A series of novel pyridyl analogues 1-18 of antiprotozoal drug 1,5-bis(4-amidinophenoxy)pentane (pentamidine) has been synthesized and tested for in vitro activities against Trypanosoma brucei rhodesiense, Plasmodium falciparum, and Leishmania donovani, and for cytotoxicity against mammalian cells. Antiprotozoal properties of compounds 1-18 depended on the placement of cationic moieties on the pyridine rings as well as the nature of substituents on the amidine groups. Diamidine 6 with cationic moieties adjacent to pyridine nitrogen atoms was the most promising compound in the series showing superior in vitro activities against T. brucei rhodesiense, P. falciparum, and L. donovani compared to pentamidine. An oral prodrug of diamidine 6, diamidoxime 9, administered at 25 mg/kg daily for 4 days, exhibited excellent antitrypanosomal efficacy in vivo curing all infected animals in the STIB900 acute mouse model of trypanosomiasis.
AuthorsSvetlana M Bakunova, Stanislav A Bakunov, Tanja Wenzler, Todd Barszcz, Karl A Werbovetz, Reto Brun, Richard R Tidwell
JournalJournal of medicinal chemistry (J Med Chem) Vol. 52 Issue 15 Pg. 4657-67 (Aug 13 2009) ISSN: 1520-4804 [Electronic] United States
PMID19606902 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiprotozoal Agents
  • Pyridines
  • Pentamidine
  • Animals
  • Antiprotozoal Agents (chemical synthesis, pharmacology)
  • Female
  • Leishmania donovani (drug effects)
  • Mice
  • Pentamidine (analogs & derivatives, chemical synthesis)
  • Plasmodium falciparum (drug effects)
  • Pyridines (chemical synthesis, pharmacology)
  • Rats
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: